Kevin Haigis

Dr. Kevin Haigis has a long-standing interest in intestinal biology and gastrointestinal cancers. He received his Ph.D. from the University of Wisconsin – Madison and performed his post-doctoral work at the Massachusetts Institute of Technology. There, he focused on the role of the RAS oncoproteins in colorectal cancer, exploring the functional differences among the RAS family members in colorectal cancer. He was a Robert Black Fellow of the Damon Runyon Cancer Research Foundation and received the Howard Temin Award K01 from the National Cancer Institute. In 2023, he was elected as a Fellow of the American Association for the Advancement of Science. Dr. Haigis has been a member of the Harvard Medical School faculty since 2007. He is currently a Professor of Medicine at Harvard Medical School and the Chief Scientific Officer at the Dana-Farber Cancer Institute. His laboratory combines computational and informatic approaches with experimental approaches in genetically engineered mice and human models to study the relationship between RAS signaling, colorectal cancer, and inflammation.